Serotonin syndrome: Early management with cyproheptadine

Annals of Pharmacotherapy

Volumn 35, Issue 7-8, 2001, Pages 870-873

  McDaniel, W W ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Cyproheptadine; Serotonin syndrome

Indexed keywords

AMITRIPTYLINE; CYPROHEPTADINE; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; LIOTHYRONINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; OLANZAPINE; SUMATRIPTAN; TRAMADOL; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COCAINE DEPENDENCE; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG OVERDOSE; FEMALE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MENTAL HEALTH; MUSCLE TONE; MYDRIASIS; PRIORITY JOURNAL; PUPIL; RECURRENT DISEASE; SEROTONIN SYNDROME; SYMPTOM;

EID: 0034921319     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10203     Document Type: Article

References (25)

1. The serotonin syndrome
2. Serotonin syndrome
3. The serotonin syndrome
4. Neurologic effects of tryptophan in a patient receiving a monoamine oxidase inhibitor
5. Isolated venlafaxine-induced serotonin syndrome
6. Serotonin syndrome associated with nefazodone and paroxetine
7. Serotonin syndrome with mirtazapine-fluoxetine combination
8. Serotonin syndrome caused by venlafaxine and lithium
9. Serotonin syndrome in combined moclobemide and venlafaxine ingestion
10. Fatal serotonin syndrome caused by moclobemide-clomipramine overdose
11. Serotonin syndrome attributed to tramadol addition to paroxetine therapy
12. Death by "ecstasy"; the serotonin syndrome?
13. Sumatriptan contraindications and the serotonin syndrome
14. Serotonin syndrome
15. The pathophysiology and management of the serotonin syndrome
16. Treatment of serotonin syndrome with cyproheptadine
17. Treatment of serotonin syndrome with cyproheptadine
18. Successful treatment of serotonin syndrome with chlorpromazine
19. The serotonin syndrome: Case responsive to propranolol
20. Relapse following clozapine withdrawal: Effect of neuroleptic drugs and cyproheptadine
21. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by monitoring of muscle twitches in the rat
22. Evaluating outcomes and choosing alternatives
23. A double-blind randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period
24. Neuroleptic malignant syndrome